Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases

Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3...

Full description

Bibliographic Details
Main Authors:	Ahmet Güner, Emrah Bayam, Semih Kalkan, Sabahattin Gündüz, Mehmet Özkan
Format:	Article
Language:	English
Published:	KARE Publishing 2019-01-01
Series:	Türk Kardiyoloji Derneği Arşivi
Subjects:	low molecular weight heparin mechanical heart valve prosthetic valve thrombosis.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-83364

id	doaj-3a380f6b59994494aa90353f9af6f211
record_format	Article
spelling	doaj-3a380f6b59994494aa90353f9af6f2112021-01-19T07:29:40ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692019-01-01471636810.5543/tkda.2018.83364TKDA-83364Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three casesAhmet Güner0Emrah Bayam1Semih Kalkan2Sabahattin Gündüz3Mehmet Özkan4Department of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, TurkeyDepartment of Cardiology, Kartal Koşuyolu High Speciality Training and Research Hospital, İstanbul, TurkeyPregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-83364low molecular weight heparinmechanical heart valveprosthetic valve thrombosis.
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Ahmet Güner Emrah Bayam Semih Kalkan Sabahattin Gündüz Mehmet Özkan
spellingShingle	Ahmet Güner Emrah Bayam Semih Kalkan Sabahattin Gündüz Mehmet Özkan Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases Türk Kardiyoloji Derneği Arşivi low molecular weight heparin mechanical heart valve prosthetic valve thrombosis.
author_facet	Ahmet Güner Emrah Bayam Semih Kalkan Sabahattin Gündüz Mehmet Özkan
author_sort	Ahmet Güner
title	Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
title_short	Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
title_full	Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
title_fullStr	Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
title_full_unstemmed	Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
title_sort	is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases
publisher	KARE Publishing
series	Türk Kardiyoloji Derneği Arşivi
issn	1016-5169
publishDate	2019-01-01
description	Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.
topic	low molecular weight heparin mechanical heart valve prosthetic valve thrombosis.
url	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-83364
work_keys_str_mv	AT ahmetguner istheuseoflowmolecularweightheparinarationalchoiceduringpregnancyinpatientswithamechanicalheartvalveareportofthreecases AT emrahbayam istheuseoflowmolecularweightheparinarationalchoiceduringpregnancyinpatientswithamechanicalheartvalveareportofthreecases AT semihkalkan istheuseoflowmolecularweightheparinarationalchoiceduringpregnancyinpatientswithamechanicalheartvalveareportofthreecases AT sabahattingunduz istheuseoflowmolecularweightheparinarationalchoiceduringpregnancyinpatientswithamechanicalheartvalveareportofthreecases AT mehmetozkan istheuseoflowmolecularweightheparinarationalchoiceduringpregnancyinpatientswithamechanicalheartvalveareportofthreecases
_version_	1724332367670149120

Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: a report of three cases

Similar Items